Efficient antibacterial agents: A review of the synthesis, biological evaluation and mechanism of pleuromutilin derivatives

Current Topics in Medicinal Chemistry

Volumn 13, Issue 24, 2013, Pages 3013-3025

  Shang, Ruofeng ^a,b,c   Wang, Jiatu ^d   Guo, Wenzhu ^a,b,c   Liang, Jianping ^a,b,c  

^a Key Lab of New Animal Drug Project   (China)

^b AGRO ENVIRONMENTAL PROTECTION INSTITUTE   (China)

^c INSTITUTE OF PLANT PROTECTION   (China)

^d GANSU UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Antibacterial activities; Antibacterial mechanism; Chemical modifications; Pleuromutilin; Resistance mechanism

Indexed keywords

AMOXICILLIN; ANTIINFECTIVE AGENT; BC 3205; BC 3781; BC 7013; CHLORAMPHENICOL; DALFOPRISTIN; LINCOSAMIDE; OXAZOLIDINONE DERIVATIVE; PLEUROMUTILIN DERIVATIVE; RETAPAMULIN; TIAMULIN; UNCLASSIFIED DRUG; VALNEMULIN; VANCOMYCIN; VIRGINIAMYCIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; BACTERIAL SKIN DISEASE; DRUG SCREENING; DRUG SYNTHESIS; HUMAN; IMPETIGO; MINIMUM INHIBITORY CONCENTRATION; MYCOPLASMOSIS; NONHUMAN; PHASE 2 CLINICAL TRIAL (TOPIC); RESPIRATORY TRACT INFECTION; REVIEW;

ANIMALS; ANTI-BACTERIAL AGENTS; BICYCLO COMPOUNDS, HETEROCYCLIC; DITERPENES; DRUG RESISTANCE, BACTERIAL; HUMANS; MOLECULAR STRUCTURE; THIOGLYCOLATES;

EID: 84890914803     PISSN: 15680266     EISSN: 18734294     Source Type: Journal    
DOI: 10.2174/15680266113136660217     Document Type: Review

References (96)

1. Spicknall, I.H.; Foxman, B.; Marrs, C.F.; Eisenberg, J.N. A Modeling Framework for the Evolution and Spread of Antibiotic Resistance: Literature Review and Model Categorization. Am. J. Epidemiol., 2013, 9, 1-13.
2. Wenchcewicz, T.A.; Yang, B.Y.; Rudloff, J.R.; Oliver, A.G.; Miller, M.J. N-O chemistry for antibiotics: discovery of N-Alkyl-N-(pyridin-2-yl)hydroxylamine scaffolds as selective antibacterial agents using nitroso Diels-Alder and ene chemistry. J. Med. Chem., 2011, 54, 6843-6858.
3. Alves, M.J.; Ferreira, I.C.; Dias, J.; Teixeira, V.; Martins, A.; Pintado, M.A. Review on Antimicrobial Activity of Mushroom (Basidiomycetes) Extracts and Isolated Compounds. Planta. Med., 2012, 78, 1707-1718
4. Raoni, S.B.G.; Marcus, V.N.S. Recent development in pleuromutilin derivatve: A Promising Class Against Bacterial Respiratory Disease. Curr. Resp. Med. Rev., 2010, 6, 91-101.
5. Kavanagh, F.; Hervey, A.; Robbins, W.J. Antibiotic Substances From Basidiomycetes: VIII. Pleurotus Multilus (Fr.) Sacc. And Pleurotus Passeckerianus Pilat. Proc. Natl. Acad. Sci. USA, 1951, 37, 570-574.
6. Arigoni, D. Structure of a new type of terpene. Gazz. Chem. Ital., 1962, 92, 884-901.
7. Birch, A.J.; Holzapfel, C.W.; Richards, R.W. Diterpenoid nature of pleuromutilin. Chem. Ind., 1963, 14, 374-375.
8. Shang, R.F.; Liu, Y.; Xin, Z.J.; Guo W.Z.; Guo Z.T.; Hao, B.C.; Liang, J.P. Synthesis and antibacterial evaluation of novel pleuromutilin derivatives. Eur. J. Med. Chem., 2013, 63, 231-238.
9. Poulsen, S.M.; Karlsson, M.; Johansson, L.B.; Vester, B. The pleuromutilin drugs tiamulin and valnemulin bind to the RNA at the peptidyl transferase centre on the ribosome. Mol. Microbiol., 2001, 41, 1091-1099.
10. Davidovich, C.; Bashan, A.; Auerbach, N.T.; Yaggie, R.D.; Gontarek, R.R.; Yonath, A. Induced-fit tightens pleuromutilins binding to ribosomes and remote interactions enable their selectivity. Proc Natl Acad Sci USA, 2007, 104, 4291-4296.
11. Long, K.S.; Hansen, L.H.; Jakobsen, L.; Vester, B. Interaction of pleuromutilin derivatives with the ribosomal peptidyl transferase center. Antimicrob. Agents Chemother., 2006, 50, 1458-1462.
12. Berner, H.; Fisher, G. Chemistry of pleuromutilins synthesis of 14-O-acetyl-19, 20- dihydro-A-nor-mutilins. Monatsh Chem., 1981, 112, 1441-1450.
13. Frank, S.; Paola, F.; Ada, Y.; Jörg, M.; Harms, S. Inhibition of peptide bond formation by pleuromutilins: the structure of the 50S ribosomal subunit from Deinococcus radiodurans in complex with tiamulin. Mol. Microbiol., 2004, 54, 1287-1294.
14. Egger H.; Reinshagen H. New pleuromutilin derivatives with enhanced antimicrobal activity. I. Synthesis. J. Atibiot., 1976, 29, 915-922.
15. Riedl K. Studies on pleuromutilin and some of its derivatives. J. Antibiot., 1976, 29, 132-139.
16. Egger, H.; Reinshagen, H. New pleuromutilin derivatives with enhanced antimicrobial activity. II. Structure-activity correlations. J. Antibiot., 1976, 29, 923-927.
17. Drews J.; Georgopoulos A.; Laber G.; Schutze, E.; Unger, J. Antimicrobial activities of 81.723 Hfu, a new pleuromutilin derivative. antimicrob, Agents Chemother., 1975, 12: 507-516.
18. Olson L.D. Tiamulin in drinking water for treatment and development of immunity to swine dysentery. J Am. Vet. Med. Assoc., 1986, 10, 1165-1170.
19. Burch, D.G.; Jones, G.T.; Heard, T.W.; Tuck, R.E. The synergistic activity of tiamulin and chlortetracycline: in-feed treatment of bacterially complicated enzootic pneumonia in fattening pigs. Vet. Rec., 1986, 5, 108-112.
20. Ulrich, K.; David, M. Tiamutin has proven synergistic activity against important respiratory pathogens when used with CTC. J. Vet., 1995, 5, 340-345.
21. Jordan, F.T.W.; Forrester, C.A.; Ripley, P.H.; Burch, D.G.S. In vitro and in vivo comparisions of the tiamulin, valnemulin, tylosin, and lincomycin,spectinomycin against mycoplasma gallisoptieum. Avian. Dis., 1998, 42, 35-39.
22. Baughn, C.O.; Alpaugh, W.C.; Linkenheimer, W.H.; Maplesden, D.C. Effect of tiamulin in chickens and turkeys infected experimentally with avian Mycoplasma. Avian Dis., 1978. 22, 620-626.
23. Hampson, D.J; Oxberry, S.L.; Stephens, C.P. Influence of in-feed zinc bacitracin and tiamulin treatment on experimental avian intestinal spirochaetosis caused by Brachyspira intermedia. Avian Pathol., 2002, 31, 285-291.
24. Stephens, C.P.; Hampson, D.J. Evaluation of tiamulin and lincomycin for the treatment of broiler breeders experimentally infected with the intestinal spirochaete Brachyspira pilosicoli. Avian Pathol., 2002, 31, 299-304.
25. Burch, D.; Harding, C.; Alvarez, R.; Valks, M. Treatment of a field case of avian intestinal spirochaetosis caused by Brachyspira pilosicoli with tiamulin. Avian Pathol., 2006, 35, 211-216.
26. Burch, D. G. Tiamulin activity against Brachyspira hyodysenteriae. Vet. Rec., 2008, 163, 760.
27. Hannan, P.C.; windsor, H.M.; Ripley, P.H. In virtro susceptibilities of recent filed isolates of Mycoplasma hyopneumoniae and Myco-plasma hyosynoviate to Valnemulin(Econor). Res. Vet. Sci., 1997, 63, 157-60.
28. Hu, C.; Zou, Y. Mutilins derivatives: from veterinary to human-used antibiotics. Mini. Rev. Med. Chem., 2009, 12, 1397-1406.
29. Jordan, F.; Forrester, C.; Ripley P.H.; Burch, D.G. In vitro and vivo comparisions of the tiamulin, valnemulin, tylosin,and lincomy-cin,spectinomycin against mycoplasma gallisoptieum. Avian Dis., 1998, 42, 35-39.
30. Karlsson, M.; Oxberry, S.L.; Hampson, D.J. Antimicrobial susceptibility testing of Australian isolates of Brachyspira hyodysenteriae using a new broth dilution method. Vet. Microbiol., 2002, 84, 123-133.
31. Stipkovits, L.; Ripley, P.H.; Tenk, M.; Glavits, R.; Molnar, T.; Fodor, L. The efficacy of valnemulin (Econor) in the control of disease caused by experimental infection of calves with Myco-plasma bovis. Res. Vet. Sci., 2005, 78, 207-215.
32. Karlsson, M.; Gunnarsson, A.; Franklin, A. Susceptibility to pleu-romutilins in Brachyspira (Serpulina) hyodysenteriae. Anim. Health Res. Rev., 2001, 2, 59-65.
33. Pringle, M.; Lánden, A.; Franklin, A. Tiamulin resistance in porcine Brachyspira pilosicoli isolates. Res. Vet. Sci., 2006, 80, 1-4.
34. Wattanaphansak, S.; Singer, R.; Gebhart, C. In vitro antimicrobial activity against 10 North American and European Lawsonia in-tracellularis isolates. Vet. Microbiol., 2009, 134, 305-310.
35. Heilmann, C.; Jensen, L.; Jensen, J.S.; Lundstrom, K.; Windsor, D.; Windsor, H.; Webster, D. Treatment of resistant mycoplasma infection in immunocompromised patients with a new pleuromutilin antibiotic. J. Infect., 2001, 43, 234-238.
36. Scangarella-Oman, N.E.; Shawar, R.M.; Bouchillon, S.; Hoban, D. Microbiological profile of a new topical antibacterial: retapamulin ointment 1%. Expert Rev. Anti. Infect. Ther., 2009, 7, 269-279.
37. European Medicines Agency. Summary of product characteristics: product information. Available from. http://www.emea.europa.eu, 2009.
38. Rittenhouse, S.; Biswas, S.; Broskey, J.; McCloskey, L.; Moore, T.; Vasey, S.; West, J.; Zalacain, M.; Zonis, R.; Payne, D. Selection of retapamulin, a novel pleuromutilin for topical use. Antimi-crob. Agents Chemother., 2006, 50, 3882-3885.
39. Novak, R.; Shlaes, D.M. The pleuromutilin antibiotics: a new class for human use. Curr Opin Investig Drugs, 2010, 11, 182-91
40. Francisco, J.C.; Gracia, M.; Juan, J.P. In vitro activity of retapa-mulin against linezolid and methicillin-resistant Staphylococcus aureus isolates. Rev. Esp. Quimioter, 2011, 24, 127-130.
41. Tomayko, J.F.; Li, G.; Breton, J.J.; Scangarella-Oman, N.; Dales-sandro, M.; Martin, M. The safety and efficacy of topical retapa-mulin ointment versus placebo ointment in the treatment of secondarily infected traumatic lesions: a randomized, double-blind superiority study. Adv Skin Wound Care., 2013, 26, 113-21.
42. Novak, R.; Shlaes, D.M. The pleuromutilin antibiotics: a new class for human use. Curr. Opin. Investig. Drugs, 2010, 11, 182-191.
43. Sader, H.S.; Biedenbach, D.J.; Paukner, S.; Ivezic-Schoenfeld, Z.; Jones, R.N. Antimicrobial Activity of the Investigational Pleu-romutilin Compound BC-3781 Tested against Gram-Positive Organisms Commonly Associated with Acute Bacterial Skin and Skin Structure Infections. Antimicrob. Agents Chemother., 2012, 56, 1619-1623.
44. Sader, H.S.; Paukner, S.; Ivezic-Schoenfeld, Z.; Biedenbach, D.J.; Schmitz, J.; Jones, R.N. Antimicrobial activity of the novel pleu-romutilin antibiotic BC-3781 against organisms responsible for community-acquired respiratory tract infections (CARTI). J. An-timicrob. Chemother., 2012, 67, 1170-1175.
45. Prince, W.T.; Ivezic-Schoenfeld, Z.; Lell, C.; Tack, K.J.; Novak, R.; Obermayr, F.; Talbot, G.H. Phase II clinical study of BC-3781, a pleuromutilin antibiotic, in treatment of patients with acute bacterial skin and skin structure infections. Antimicrob Agents Che-mother, 2013, 57, 2087-2094.
46. Ross, J.E.; Sader, H.S.; Ivezic-Schoenfeld, Z.; Paukner, S.; Jones, R.N. Disk diffusion and MIC quality control ranges for BC-3205 and BC-3781, two novel pleuromutilin antibiotics. J. Clin. Micro-biol., 2012, 50, 3361-3364.
47. Biedenbach, D.J.; Jones, R.N.; Ivezic-Schönfeld, Z.; Paukner, S.; Novak, R. In vitro antibacterial spectrum of BC-7013, a novel pleu-romutilin derivative for topical use in humans. Interscience Conference on Antimicrobial Agents and Chemotherapy, 2009, 49, Abs F1, 1521.
48. Tang, Y.Z.; Liu, Y.H.; Chen, J.X. Pleuromutilin and its derivatives-the lead compounds for novel antibiotics. Mini. Rev. Med. Chem., 2012, 12, 53-61.
49. Hodgin, L.A.; Hogenauer, G. The mode of action of pleuromutilin derivatives: Effect on cell-free polypetide synthesis. Eur. J. Bio-chem., 1974, 47, 527-533.
50. Hogenauer, G.; Forschungsinstitut, S. The mode of action of Pleu-romutilin Derivatives: Location and properties of the Pleuromutilin binding site on Escherichia coli ribosomers. Eur. J. Biochem., 1975, 52, 93-98.
51. Hogenauer, G.; Ruf, C. Ribosomal binding region for the antibiotic tiamulin: stoichiometry, subunit location, and affinity for various analogs. Antimicrob. Agents Chemother., 1981. 19, 260-265.
52. Novak, R. Are pleuromutilin antibiotics finally fit for human use? Ann. N. Y. Acad. Sci., 2011. 1241, 71-81.
53. Poulsen, S.M.; Karlsson, M.; Johansson, L.B.; Vester, B. The pleu-romutilin drugs tianmulin and valnemulin bind to the RNA at the peptidyl transferase centre on the ribosome. Mol. Microbiol., 2001, 41, 1091-1099.
54. Schlunzen, F.; Pyetan, E.; Fucini, P.; Yonath, A.; Harms, J.M. Inhibition of petide bond formation by pleueomutilins: the structure of 50S ribosomal subunit from Deinococcus radiodurans in complex with tiamulin. Mol. Microbiol., 2004, 54, 1287-1294.
55. Davidovich, C.; Bashan, A.; Auerbach-Nevo, T.; Yaggie, R.D.; Gontarek, R.R.; Yonath, A. Induced-fit tightens pleuromutilins, binding to ribosomes and remote interactions enable their selectivity. Proc. Natl. Acad. Sci. USA, 2007, 104, 4291-4296.
56. Schmeing, T.M.; Seila, A.C.; Hansen, J.L.; Freeborn, B.; Soukup, J.K.; Scaringe, S.A.; Strobel, S.A.; Moore, P.B.; Steitz, T.A. A pre-translocational intermediate in protein synthesis observed in crystals of enzymatically active 50S subunits. Nat. Struct. Biol., 2002, 9, 225-230.
57. Bashan, A.; Agmon, I.; Zarivach, R.; Schluenzen, F.; Harms, J.; Berisio, R.; Bartels, H.; Franceschi, F.; Auerbach, T.; Hansen, H.A.; Kossoy, E. Structural basis of the ribosomal machinery for peptide bond formation, translocation, and nascent chain progression. Mol. Cell., 2003, 11, 91-102.
58. Yan, K.; Madden, L.; Choudhry, A.E.; Voigt, C.S.; Copeland, R.A.; Gontarek, R.R. Biochemical characterization of the interactions of the novel pleuromutilin derivative retapamulin with bacterial ribosomes. Antimicrob. Agents Chemother., 2006, 50, 3875-3881.
59. Long, K.S.; Hansen, L.H.; Jakobsen, L.; Vester, B. Interaction of pleuromutilin derivatives with the ribosomal peptidyl transferase center. Antimicrob. Agents Chemother., 2006, 50, 1458-1462.
60. Li, B.B.; Wendlandt, S.; Yao, J.N.; Liu, Y.Q.; Zhang, Q.; Shi, Z.X.; Wei, J.C.; Shao, D.H.; Schwarz, S.; Wang, S.H.; Ma Z.Y. Detection and new genetic environment of the pleuromutilin-lincosamide- streptogramin A resistance gene lsa(E) in methicillin resistant Staphylococcus aureus of swine origin. J. Antimicrob. Chemother., 2013, 5, 23-28.
61. Long, K.S; Poehlsgaard, J.; Hansen, L.H.; Hobbie, S.N.; Böttger, E.C.; Vester, B. Single 23S rRNA mutations at the ribosomal pep-tidyl transferase centre confer resistance to valnemulin and other antibiotics in Mycobacterium smegmatis by perturbation of the drug binding pocket. Mol. Microbiol., 2009, 71, 1218-27.
62. Li, B.B.; Shen, J.Z.; Cao, X.Y.; Wang Y.; Dai, L.; Huang, S.Y.; Wu, C.M. Mutations in 23S rRNA gene associated with decreased susceptibility to tiamulin and valnemulin in Mycoplasma gallisep-ticum. FEMS Microbiol. Lett., 2010, 308, 144-149.
63. Karlsson, M.; Gunnarsson, A.; Franklin, A. Susceptibility to pleu-romutilins in Brachyspira (Serpulina) hyodysenteriae. Anim. Health Res. Rev., 2001, 2, 59-65.
64. Pringle, M.; Poehlsgaard, J.; Vester B., Long, K.S. Mutations in ribosomal protein L3 and 23S ribosomal RNA at the peptidyl trans-ferase centre are associated with reduced susceptibility to tiamulin in Brachyspira spp. isolates. Mol. Microbiol., 2004. 54, 1295-1306.
65. Gentry, D.R.; Rittenhouse, S.F; McCloskey, L.; Holmes, D.J. Stepwise exposure of Staphylococcus aureus to pleuromutilins is associated with stepwise acquisition of mutations in rplC and minimally affects susceptibility to retapamulin. Antimicrob. Agents Chemother., 2007, 51, 2048-2052.
66. Kosowska-Shick, K.; Clark, C.; Credito, K.; McGhee, P.; Dewasse, B.; Bogdanovich, T.; Appelbaum, P.C. Single and multistep resistance selection studies on the activity of retapamulin compared to other agents against Staphylococcus aureus and Streptococcus pyo-genes. Antimicrob. Agents Chemother., 2006, 50, 765-769.
67. Long, K.S.; Poehlsgaard, J.; Kehrenberg, C.; Schwarz, S.; Vester, B. The Cfr rRNA methyltransferase confers resistance to Phenicols, Lincosamides, Oxazolidinones, Pleuromutilins, and Streptogramin A antibiotics. Antimicrob. Agents Chemother., 2006, 50, 2500-2505.
68. Kadlec, K.; Pomba, C.F.; Couto, N.; Schwarz, S. Small plasmids carrying vga(A) or vga(C) genes mediate resistance to lin-cosamides, pleuromutilins and streptogramin A antibiotics in me-thicillin-resistant Staphylococcus aureus ST398 from swine. J. An-timicrob. Chemother., 2010, 65, 2692-2693.
69. Schwendener, S.; Perreten, V. New transposon Tn6133 in methicil-linresistant Staphylococcus aureus ST398 contains vga(E), a novel steptogramin A, pleuromutilin, and lincosamide resistance gene. Antimicrob. Agents Chemother., 2011, 55, 4900-4904.
70. Gentry, D.R.; McCloskey, L.; Gwynn, M.N.; Rittenhouse, S.F.; Scangarella, N.; Shawar, R.; Holmes, D.J. Genetic characterization of Vga ABC proteins conferring reduced susceptibility to pleu-romutilins in Staphylococcus aureus. Antimicrob. Agents Che-mother., 2008, 52, 4507-1509.
71. Hauschild, T.; Feßler, A.T.; Kadlec, K.; Billerbeck, C.; Schwarz, S. Detection of the novel vga(E) gene in methicillin-resistant Staphy-lococcus aureus CC398 isolates from cattle and poultry. J. Antimi-crob. Chemother., 2012, 67, 503-504.
72. Malbruny, B.; Werno, A.M.; Murdoch, D.R.; Leclercq, R.; Cattoir, V. Cross-resistance to lincosamides, streptogramins A, and pleu-romutilins due to the lsa(C) gene in Streptococcus agalactiae UCN70. Antimicrob. Agents Chemother., 2011, 55, 1470-1474.
73. Wendlandt, S.; Lozano, C.; Kadlec, K.; Gomez-Sanz, E.; Zarazaga, M.; Torres, C.; Schwarz, S. The enterococcal ABC transporter gene lsa(E) confers combined resistance to lincosamides, pleuromutilins and streptogramin A antibiotics in methicillin-susceptible and me-thicillinresistant Staphylococcus aureus. J. Antimicrob. Che-mother., 2013, 68, 473-475.
74. Hunt, E. Pleuromutilin antibiotics. Drugs Future, 2000, 25, 1163-1168.
75. Wang, R.; Yuan, L.G.; He, L.M.; Zhu, L.X.; Luo, X.Y.; Zhang, C.Y.; Yu, J.J. Fang, B.H. Liu, Y.H. Pharmacokinetics and bioavail-ability of valnemulin in broiler chickens. J. Vet. Pharmacol. Ther., 2011, 34, 247-251.
76. Xu, K.P.; Zhang, Y.Y.; Sun, Y.X. Liu, J.H.; Yang, B.; Wang, Y.Z.; Wang, Y.L. Novel pleuromutilin derivatives with excellent antibacterial activity against Staphylococcus aureus. Chem. Biol. Drug. Des., 2009, 73, 655-660.
77. Zhang, Y.Y.; Xu, K.P.; Ren, D.; Ge, S.R.; Wang, Y.L.; Wang, Y.Z. Synthesis and Antibacterial Activities of Pleuromutilin Derivatives. Chinese Chem. Lett., 2009, 20, 29-31.
78. Xu, K.P.; Zhang, Y.Y.; Luo, J.; Chen, S.L.; Wang, Y.L. Study on the structure-activity relations of pleuromutilin derivatives with an aromatic amide and a thioether group in the C14 side chain. J. Chem. Res., 2010, 6, 354-357.
79. Ling, Y.; Wang, X.Y.; Wang, H.; Yu, J.H.; Tang, J.M.; Wang, D.G.; Chen, G.T.; Huang, J.H.; Li, Y.Q. Zheng, H. Design, synthesis, and antibacterial activity of novel pleuromutilin derivatives bearing an amino thiazolyl ring. Arch. Pharm. (Weinheim), 2012, 345, 638-646.
80. Wang X.Y.; Ling Y.; Wang H.; Yu, J.H.; Tang, J.M.; Zheng, H.; Zhao, X.; Wang, D.G.; Chen, G.T.; Qiu, W.Q.; Tao, J.H. Novel pleuromutilin derivatives as antibacterial agents: Synthesis, biological evaluation and molecular docking studies. Bioorg. Med. Chem. Lett., 2012, 22, 6166-6172.
81. Brooks, G.; Burgess, W.; Colthurst, D.; Hinks, J.D.; Hunt, E.; Pearson, M.J.; Shea, B.; Takle, A.K.; Wilson, J.M.; Woodnutt, G. Pleuromutilins, Part 1: The Identification of Novel Mutilin 14-Carbamates. Bioorg. Med. Chem., 2001, 9, 1221-1231.
82. Fu, L.Q.; Jiang, Z.T.; Cai, Z.; Liu, X.; He, H.L.; Yang, Y.S. Water-soluble phosphate prodrugs of pleuromutilin analogues with potent in vivo antibacterial activity against Gram-positive pathogens. Bioorg. Med. Chem. Lett., 2009, 19, 5407-5410.
83. Fu, L.Q.; Liu, X.; Ling, C.Y.; Cheng, J.J.; Guo, X.S.; He, H.L.; Ding, S.; Yang, Y.S. Design, synthesis, and structure-activity relationship studies of conformationally restricted mutilin 14-carbamates. Bioorg. Med. Chem. Lett., 2012, 22, 814-819.
84. Fu, L.Q.; Chen, Y.G.; Guo, X.S.; He, H.L.; Yang, Y.S. Synthesis and antibacterial activity of pleuromutilin derivatives with novel C(14) side chain. Chinese Chem. Lett., 2012, 23, 9-12.
85. Lolk, L.; Pøhlsgaard, J.; Jepsen, A.S.; Hansen, L.H.; Nielsen, H.; Steffansen, S.I.; Sparving, L.; Nielsen, A.B.; Vester, B.; Nielsen, P. A click chemistry approach to pleuromutilin conjugates with nu-cleosides or acyclic nucleoside derivatives and their binding to the bacterial ribosome. J. Med. Chem., 2008, 51, 4957-4967.
86. Dreier, I.; Kumar, S.; Sondergaard, H.; Rasmussen, M.L.; Hansen, L.H.; List, N.H.; Kongsted, J.; Vester, B.; Nielsen, P. A click chemistry approach to pleuromutilin derivatives, part 2: conjugates with acyclic nucleosides and their ribosomal binding and antibacterial activity. J. Med. Chem., 2012, 55, 2067-2077.
87. Gibbons, E.G. Total synthesis of (.+-.)-pleuromutilin. J. Am. Chem. Soc., 1982, 104, 1767-1769.
88. Boeckman, R.K.; Springer, D.M.; Alessi, T.R. Synthetic studies directed toward naturally occurring cyclooctanoids. 2. A stereocon-trolled assembly of (.+-.)-pleuromutilin via a remarkable sterically demanding oxy-Cope rearrangement. J. Am. Chem. Soc., 1989, 111, 8284-8286.
89. Helm, M.D.; Da Silva, M.; Sucunza, D.; Findley, T.J.; Procter, D.J. A dialdehyde cyclization cascade: an approach to pleuromutilin. Angew. Chem. Int. Ed. Engl., 2009, 48, 9315-9317.
90. Fazakerley, N.J.; Helm, M.D.; Procter, D.J. Total synthesis of (+)-pleuromutilin. Chemistry, 2013, 19, 6718-6723.
91. Fischbach, M.A.; Walsh,C.T. Antibiotics for emerging pathogens. Science, 2009, 325, 1089-1093.
92. Charest, M.G.; Lerner, C.D.; Brubaker, J.D.; Siegel, D.R.; Myers, A.G. A convergent enantioselective route to structurally diverse 6-deoxytetracycline antibiotics. Science, 2005, 308, 395-398.
93. Helm, M.D.; Da Silva, M.; Sucunza, D.; Findley, T.J.; Procter, D.J. A dialdehyde cyclization cascade: an approach to pleuromutilin. Angew. Chem. Int. Ed. Engl., 2009, 48, 9315-9317.
94. Findley, T.J.; Sucunza, D.; Miller, L.C.; Helm, M.D.; Helliwell, M.; Davies, D.T.; Procter, D.J. A stereoselective, Sm(II)-mediated approach to decorated cis-hydrindanes: synthetic studies on fauri-none and pleuromutilin. Org. Biomol. Chem., 2011, 9, 2433-2451.
95. Liu, J.; Lotesta, S.D.; Sorensen, E.J. A concise synthesis of the molecular framework of pleuromutilin. Chem. Commun (Camb)., 2011, 47, 1500-1502.
96. Lotesta, S.D.; Liu, J.; Yates, E.V.; Krieger, I.; Sacchettini, J.C.; Freundlich, J.S.; Sorensen, E.J. Expanding the pleuromutilin class of antibiotics by de novo chemical synthesis. Chem. Sci., 2011, 2, 1258-1261.